Multiclass classification of breast cancer histopathology images using multilevel features of deep convolutional neural network

被引:0
作者
Zabit Hameed
Begonya Garcia-Zapirain
José Javier Aguirre
Mario Arturo Isaza-Ruget
机构
[1] University of Deusto,eVida Research Group
[2] University Hospital of Alava,Bioaraba Health Research Institute, Oncology Diagnostics and Therapeutics Area, Department of Pathological Anatomy
[3] University of the Basque Country (UPV/EHU),NanoBioCel Research Group, School of Pharmacy
[4] Biokeralty Reseach Institute,undefined
[5] Fundación Universitaria Sanitas,undefined
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer is a common malignancy and a leading cause of cancer-related deaths in women worldwide. Its early diagnosis can significantly reduce the morbidity and mortality rates in women. To this end, histopathological diagnosis is usually followed as the gold standard approach. However, this process is tedious, labor-intensive, and may be subject to inter-reader variability. Accordingly, an automatic diagnostic system can assist to improve the quality of diagnosis. This paper presents a deep learning approach to automatically classify hematoxylin-eosin-stained breast cancer microscopy images into normal tissue, benign lesion, in situ carcinoma, and invasive carcinoma using our collected dataset. Our proposed model exploited six intermediate layers of the Xception (Extreme Inception) network to retrieve robust and abstract features from input images. First, we optimized the proposed model on the original (unnormalized) dataset using 5-fold cross-validation. Then, we investigated its performance on four normalized datasets resulting from Reinhard, Ruifrok, Macenko, and Vahadane stain normalization. For original images, our proposed framework yielded an accuracy of 98% along with a kappa score of 0.969. Also, it achieved an average AUC-ROC score of 0.998 as well as a mean AUC-PR value of 0.995. Specifically, for in situ carcinoma and invasive carcinoma, it offered sensitivity of 96% and 99%, respectively. For normalized images, the proposed architecture performed better for Makenko normalization compared to the other three techniques. In this case, the proposed model achieved an accuracy of 97.79% together with a kappa score of 0.965. Also, it attained an average AUC-ROC score of 0.997 and a mean AUC-PR value of 0.991. Especially, for in situ carcinoma and invasive carcinoma, it offered sensitivity of 96% and 99%, respectively. These results demonstrate that our proposed model outperformed the baseline AlexNet as well as state-of-the-art VGG16, VGG19, Inception-v3, and Xception models with their default settings. Furthermore, it can be inferred that although stain normalization techniques offered competitive performance, they could not surpass the results of the original dataset.
引用
收藏
相关论文
共 73 条
  • [1] Sung H(2021)Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 71 209-249
  • [2] Feng Y(2018)Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis Genes Dis. 5 77-106
  • [3] Vuong D(2014)Molecular classification of breast cancer Virchows Arch. 465 1-14
  • [4] Simpson PT(2013)Computed-aided diagnosis (CAD) in the detection of breast cancer Eur. J. Radiol. 82 417-423
  • [5] Green B(2017)Early diagnosis of breast cancer Sensors 17 1572-1411
  • [6] Cummings MC(2014)Breast cancer histopathology image analysis: A review IEEE Trans. Biomed. Eng. 61 1400-8
  • [7] Lakhani SR(2019)Comparative analysis of confocal microscopy on fresh breast core needle biopsies and conventional histology Diagnost. Pathol. 14 1-1132
  • [8] Dromain C(2020)Breast cancer histopathology image classification using an ensemble of deep learning models Sensors 20 4373-273
  • [9] Wang L(2015)Diagnostic concordance among pathologists interpreting breast biopsy specimens JAMA 313 1122-987
  • [10] Veta M(2020)Artificial intelligence in digital breast pathology: Techniques and applications The Breast 49 267-444